TherapeuticsMD (TXMD) Asset Utilization Ratio (2011 - 2026)
TherapeuticsMD's (TXMD) quarterly Asset Utilization Ratio came in at 0.09 in Q2 2026, up 30.56% on a YoY basis from 0.07 in Q2 2025, and down 2.31% quarter-over-quarter from 0.09 in Q1 2026.
Powered by 
Analysis
TherapeuticsMD (TXMD) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has reported Asset Utilization Ratio for 15 consecutive years, with 0.09 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Asset Utilization Ratio rose 30.56% year-over-year to 0.09; the trailing twelve-month figure through Jun 2026 stood at 0.09 (up 30.56% YoY), and the FY2025 full-year result was 0.08, up 84.29% from the prior year.
- Asset Utilization Ratio retreated to 0.09 in Q2 2026 per TXMD's latest filing, from 0.09 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.33 in Q3 2023 and bottomed at 0.03 in Q2 2024.
- Historically, Asset Utilization Ratio has averaged 0.31 across 5 years, with a median of 0.08 in 2025.
- The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio soared 830.44% in 2023, then sank 97.82% in 2024.
- Over 5 years, Asset Utilization Ratio stood at 0.62 in 2022, then tumbled by 95.19% to 0.03 in 2023, then jumped by 49.69% to 0.04 in 2024, then surged by 76.21% to 0.08 in 2025, then increased by 9.96% to 0.09 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.09, 0.09, and 0.08 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 0.57 |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 0.31 |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 0.56 |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 0.36 |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 0.69 |
| 10 | TherapeuticsMD | 25.35 Mn | 16.16 Mn | - | 0.09 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.09 |
| Mar 31, 2026 | 0.09 |
| Dec 31, 2025 | 0.08 |
| Sep 30, 2025 | 0.07 |
| Jun 30, 2025 | 0.07 |
| Mar 31, 2025 | 0.05 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.04 |
| Jun 30, 2024 | 0.03 |
| Mar 31, 2024 | 0.03 |
| Dec 31, 2023 | 0.03 |
| Sep 30, 2023 | 1.33 |
| Jun 30, 2023 | 1.23 |
| Mar 31, 2023 | 0.93 |
| Dec 31, 2022 | 0.62 |
| Sep 30, 2022 | 0.14 |
| Jun 30, 2022 | 0.32 |
| Mar 31, 2022 | 0.45 |
| Dec 31, 2021 | 0.46 |
| Sep 30, 2021 | 0.43 |